Literature DB >> 19474391

A role of the (pro)renin receptor in neuronal cell differentiation.

Aurelie Contrepas1, Joy Walker, Annette Koulakoff, Karl J Franek, Fatimunnisa Qadri, Christian Giaume, Pierre Corvol, Charles E Schwartz, Genevieve Nguyen.   

Abstract

The (pro)renin receptor [(P)RR] plays a pivotal role in the renin-angiotensin system. Experimental models emphasize the role of (P)RR in organ damage associated with hypertension and diabetes. However, a mutation of the (P)RR gene, resulting in frame deletion of exon 4 [Delta4-(P)RR] is associated with X-linked mental retardation (XLMR) and epilepsy pointing to a novel role of (P)RR in brain development and cognitive function. We have studied (P)RR expression in mouse brain, as well as the effect of transfection of Delta4-(P)RR on neuronal differentiation of rat neuroendocrine PC-12 cells induced by nerve growth factor (NGF). In situ hybridization showed a wide distribution of (P)RR, including in key regions involved in the regulation of blood pressure and body fluid homeostasis. In mouse neurons, the receptor is on the plasma membrane and in synaptic vesicles, and stimulation by renin provokes ERK1/2 phosphorylation. In PC-12 cells, (P)RR localized mainly in the Golgi and in endoplasmic reticulum and redistributed to neurite projections during NGF-induced differentiation. In contrast, Delta4-(P)RR remained cytosolic and inhibited NGF-induced neuronal differentiation and ERK1/2 activation. Cotransfection of PC-12 cells with (P)RR and Delta4-(P)RR cDNA resulted in altered localization of (P)RR and inhibited (P)RR redistribution to neurite projections upon NGF stimulation. Furthermore, (P)RR dimerized with itself and with Delta4-(P)RR, suggesting that the XLMR and epilepsy phenotype resulted from a dominant-negative effect of Delta4-(P)RR, which coexists with normal transcript in affected males. In conclusion, our results show that (P)RR is expressed in mouse brain and suggest that the XLMR and epilepsy phenotype might result from a dominant-negative effect of the Delta4-(P)RR protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474391      PMCID: PMC2724237          DOI: 10.1152/ajpregu.90832.2008

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  29 in total

1.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

2.  Molecular anatomy of a trafficking organelle.

Authors:  Shigeo Takamori; Matthew Holt; Katinka Stenius; Edward A Lemke; Mads Grønborg; Dietmar Riedel; Henning Urlaub; Stephan Schenck; Britta Brügger; Philippe Ringler; Shirley A Müller; Burkhard Rammner; Frauke Gräter; Jochen S Hub; Bert L De Groot; Gottfried Mieskes; Yoshinori Moriyama; Jürgen Klingauf; Helmut Grubmüller; John Heuser; Felix Wieland; Reinhard Jahn
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

3.  Elevated blood pressure and heart rate in human renin receptor transgenic rats.

Authors:  Céline A Burcklé; A H Jan Danser; Dominik N Müller; Ingrid M Garrelds; Jean-Marie Gasc; Elena Popova; Ralph Plehm; Jörg Peters; Michael Bader; Geneviève Nguyen
Journal:  Hypertension       Date:  2006-01-09       Impact factor: 10.190

4.  Prorenin and its ancient receptor.

Authors:  Céline Burcklé; Michael Bader
Journal:  Hypertension       Date:  2006-08-28       Impact factor: 10.190

5.  Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules.

Authors:  J Ludwig; S Kerscher; U Brandt; K Pfeiffer; F Getlawi; D K Apps; H Schägger
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

6.  Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen.

Authors:  M Schinke; O Baltatu; M Böhm; J Peters; W Rascher; G Bricca; A Lippoldt; D Ganten; M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

7.  A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein.

Authors:  Jan H Schefe; Mario Menk; Jana Reinemund; Karin Effertz; Robin M Hobbs; Pier Paolo Pandolfi; Patricia Ruiz; Thomas Unger; Heiko Funke-Kaiser
Journal:  Circ Res       Date:  2006-11-02       Impact factor: 17.367

8.  A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor.

Authors:  Juliane Ramser; Fatima E Abidi; Celine A Burckle; Claus Lenski; Helga Toriello; Gaiping Wen; Herbert A Lubs; Stefanie Engert; Roger E Stevenson; Alfons Meindl; Charles E Schwartz; Genevieve Nguyen
Journal:  Hum Mol Genet       Date:  2005-03-03       Impact factor: 6.150

9.  Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study.

Authors:  J M Gasc; S Shanmugam; M Sibony; P Corvol
Journal:  Hypertension       Date:  1994-11       Impact factor: 10.190

10.  Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains.

Authors:  V J Dzau; J Ingelfinger; R E Pratt; K E Ellison
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

View more
  31 in total

1.  A map and new directions for the (pro)renin receptor in the brain: focus on "A role of the (pro)renin receptor in neuronal cell differentiation".

Authors:  Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-03       Impact factor: 3.619

2.  X-linked mental retardation gene CUL4B targets ubiquitylation of H3K4 methyltransferase component WDR5 and regulates neuronal gene expression.

Authors:  Tadashi Nakagawa; Yue Xiong
Journal:  Mol Cell       Date:  2011-08-05       Impact factor: 17.970

3.  (Pro)renin receptor knockdown in the paraventricular nucleus of the hypothalamus attenuates hypertension development and AT1 receptor-mediated calcium events.

Authors:  Lucas A C Souza; Caleb J Worker; Wencheng Li; Fatima Trebak; Trevor Watkins; Ariana Julia B Gayban; Evan Yamasaki; Silvana G Cooper; Bernard T Drumm; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

Review 4.  The (pro)renin receptor and its interaction partners.

Authors:  Jörg Peters
Journal:  Pflugers Arch       Date:  2017-06-15       Impact factor: 3.657

5.  Involvement of the brain (pro)renin receptor in cardiovascular homeostasis.

Authors:  Zhiying Shan; Peng Shi; Adolfo E Cuadra; Ying Dong; Gwyneth J Lamont; Qiuhong Li; Dale M Seth; L Gabriel Navar; Michael J Katovich; Colin Sumners; Mohan K Raizada
Journal:  Circ Res       Date:  2010-08-05       Impact factor: 17.367

Review 6.  Renin and prorenin receptor in hypertension: what's new?

Authors:  Genevieve Nguyen
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

7.  Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.

Authors:  Wencheng Li; Michelle N Sullivan; Sheng Zhang; Caleb J Worker; Zhenggang Xiong; Robert C Speth; Yumei Feng
Journal:  Hypertension       Date:  2014-11-24       Impact factor: 10.190

8.  Aliskiren reduces the release of soluble (pro)renin receptor from human umbilical vein endothelial cells.

Authors:  Shinji Yamashita; Kazal Boron Biswas; A H M Nurun Nabi; Tsutomu Nakagawa; Fumiaki Suzuki; Akio Ebihara
Journal:  Biomed Rep       Date:  2018-07-05

Review 9.  Angiotensin-II, the Brain, and Hypertension: An Update.

Authors:  Colin N Young; Robin L Davisson
Journal:  Hypertension       Date:  2015-08-31       Impact factor: 10.190

10.  Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).

Authors:  Olena Korvatska; Nicholas S Strand; Jason D Berndt; Tim Strovas; Dong-Hui Chen; James B Leverenz; Konstantin Kiianitsa; Ignacio F Mata; Emre Karakoc; J Lynne Greenup; Emily Bonkowski; Joseph Chuang; Randall T Moon; Evan E Eichler; Deborah A Nickerson; Cyrus P Zabetian; Brian C Kraemer; Thomas D Bird; Wendy H Raskind
Journal:  Hum Mol Genet       Date:  2013-04-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.